Future directions in Alzheimer's disease from risk factors to prevention

Biochemical Pharmacology

Volumn 88, Issue 4, 2014, Pages 661-670

  Imtiaz, Bushra ^a   Tolppanen, Anna Maija ^a   Kivipelto, Miia ^a,b   Soininen, Hilkka ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b AGING RESEARCH CENTER   (Sweden)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Dementia; Prevention; Randomized controlled trials; Risk scores

Indexed keywords

ALCOHOL; CHOLESTEROL;

AGE; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; BODY MASS; CAIDE DEMENTIA RISK SCORE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COGNITION; DIETARY INTAKE; EDUCATIONAL STATUS; ENVIRONMENTAL FACTOR; FRAMINGHAM RISK SCORE; GENETIC RISK; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE; LOAD RISK SCORE; MULTIINFARCT DEMENTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; TYPE 2 DIABETES SPECIFIC DEMENTIA RISK SCORE;

ALZHEIMER'S DISEASE; DEMENTIA; PREVENTION; RANDOMIZED CONTROLLED TRIALS; RISK SCORES;

ALZHEIMER DISEASE; CARDIOVASCULAR DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; RISK FACTORS;

EID: 84897954480     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.01.003     Document Type: Review

References (98)

1. M. Prince, R. Bryce, E. Albanese, A. Wimo, W. Ribeiro, and C.P. Ferri The global prevalence of dementia: a systematic review and metaanalysis Alzheimers Dement 9 1 2013 63 7500
2. A.L. Sosa-Ortiz, I. Acosta-Castillo, and M.J. Prince Epidemiology of dementias and Alzheimer's disease Arch Med Res 43 8 2012 600 608
3. C.P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, and M. Ganguli et al. Global prevalence of dementia: a Delphi consensus study Lancet 366 9503 2005 2112 2117 (Pubitemid 41797645)
4. J.M. Lage 100 years of Alzheimer's disease (1906-2006) J Alzheimers Dis 9 3 Suppl 2006 15 26 (Pubitemid 44253294)
5. M.C. Carrillo, R.A. Dean, F. Nicolas, D.S. Miller, R. Berman, and Z. Khachaturian et al. Revisiting the framework of the National Institute on Aging-Alzheimer's association diagnostic criteria Alzheimers Dement 9 5 2013 594 601
6. S.A. Ligthart, E.P. Moll van Charante, W.A. Van Gool, and E. Richard Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review Vasc Health Risk Manag 6 2010 775 785
7. Y.D. Reijmer, E. Van den Berg, J.M. Dekker, G. Nijpels, C.D. Stehouwer, and L.J. Kappelle et al. Development of vascular risk factors over 15 years in relation to cognition: the Hoorn study J Am Geriatr Soc 60 8 2012 1426 1433
8. J.J. Virta, K. Heikkila, M. Perola, M. Koskenvuo, I. Raiha, and J.O. Rinne et al. Midlife cardiovascular risk factors and late cognitive impairment Eur J Epidemiol 28 5 2013 405 416
9. R.A. Whitmer, S. Sidney, J. Selby, S.C. Johnston, and K. Yaffe Midlife cardiovascular risk factors and risk of dementia in late life Neurology 64 2 2005 277 281
10. M. Kivipelto, T. Ngandu, L. Fratiglioni, M. Viitanen, I. Kareholt, and B. Winblad et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease Arch Neurol 62 10 2005 1556 1560 (Pubitemid 41434560)
11. S. Kaffashian, A. Dugravot, E.J. Brunner, S. Sabia, J. Ankri, and M. Kivimaki et al. Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study Alzheimers Dement 9 5 2013 572 579
12. J.A. Luchsinger, C. Reitz, L.S. Honig, M.X. Tang, S. Shea, and R. Mayeux Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology 65 4 2005 545 551 (Pubitemid 41170713)
13. M. Vuorinen, A. Solomon, S. Rovio, L. Nieminen, I. Kareholt, and J. Tuomilehto et al. Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study Dement Geriatr Cogn Disord 31 2 2011 119 125
14. D. Knopman, L.L. Boland, T. Mosley, G. Howard, D. Liao, and M. Szklo et al. Cardiovascular risk factors and cognitive decline in middle-aged adults Neurology 56 1 2001 42 48 (Pubitemid 32059650)
15. M. Kivipelto, E.L. Helkala, M.P. Laakso, T. Hanninen, M. Hallikainen, and K. Alhainen et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study BMJ 322 7300 2001 1447 1451 (Pubitemid 32575406)
16. E.S. Korf, L.R. White, P. Scheltens, and L.J. Launer Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia aging study Hypertension 44 1 2004 29 34 (Pubitemid 38823483)
17. I. Skoog, B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, and L. Nilsson et al. 15-year longitudinal study of blood pressure and dementia Lancet 347 9009 1996 1141 1145 (Pubitemid 126512042)
18. M. Vuorinen, I. Kareholt, V. Julkunen, G. Spulber, E. Niskanen, and T. Paajanen et al. Changes in vascular factors 28 years from midlife and late-life cortical thickness Neurobiol Aging 34 1 2013 100 109
19. M.C. Power, J. Weuve, J.J. Gagne, M.B. McQueen, A. Viswanathan, and D. Blacker The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis Epidemiology 22 5 2011 646 659
20. N.S. Shah, J.S. Vidal, K. Masaki, H. Petrovitch, G.W. Ross, and C. Tilley et al. Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: the Honolulu Asia aging study Hypertension 59 4 2012 780 786
21. P. Van Vliet, W. Van de Water, A.J. De Craen, and R.G. Westendorp The influence of age on the association between cholesterol and cognitive function Exp Gerontol 44 1-2 2009 112 122
22. A. Solomon, I. Kareholt, T. Ngandu, B. Winblad, A. Nissinen, and J. Tuomilehto et al. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study Neurology 68 10 2007 751 756 (Pubitemid 46667900)
23. A.M. Tolppanen, T. Ngandu, I. Kareholt, T. Laatikainen, M. Rusanen, and H. Soininen et al. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort J Alzheimers Dis 2013
24. R.A. Whitmer, E.P. Gunderson, C.P. Quesenberry Jr., J. Zhou, and K. Yaffe Body mass index in midlife and risk of Alzheimer disease and vascular dementia Curr Alzheimer Res 4 2 2007 103 109 (Pubitemid 46557496)
25. J.A. Luchsinger, and D.R. Gustafson Adiposity, type 2 diabetes, and Alzheimer's disease J Alzheimers Dis 16 4 2009 693 704
26. A.L. Fitzpatrick, L.H. Kuller, O.L. Lopez, P. Diehr, E.S. O'Meara, and W.T. Longstreth et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study Arch Neurol 66 3 2009 336 342
27. A.M. Tolppanen, P. Lavikainen, A. Solomon, M. Kivipelto, M. Uusitupa, and H. Soininen et al. History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study Diabetes Care 36 7 2013 2015 2019
28. N.T. Vagelatos, and G.D. Eslick Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship Epidemiol Rev 2013
29. M.W. Strachan, R.M. Reynolds, R.E. Marioni, and J.F. Price Cognitive function, dementia and type 2 diabetes mellitus in the elderly Nat Rev Endocrinol 7 2 2011 108 114
30. H. Umegaki, T. Hayashi, and H. Nomura et al. Cognitive dysfunction: an emerging concept of a new diabetic complication in the elderly Geriatr Gerontol Int 13 1 2013 28 34
31. R.O. Kuljis, and M. Salkovic-Petrisic Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics J Alzheimers Dis 25 1 2011 29 41
32. W. Farris, S. Mansourian, and Y. Chang et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci U S A 100 7 2003 4162 4167 (Pubitemid 36418174)
33. N. Cherbuin, P. Sachdev, and K.J. Anstey Higher normal fasting plasma glucose is associated with hippocampal atrophy: the PATH study Neurology 79 10 2012 1019 1026
34. K. Yaffe, C. Falvey, and N. Hamilton et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia Arch Neurol 69 9 2012 1170 1175
35. Y. Stern, B. Gurland, T.K. Tatemichi, M.X. Tang, D. Wilder, and R. Mayeux Influence of education and occupation on the incidence of Alzheimer's disease JAMA 271 13 1994 1004 1010 (Pubitemid 24099921)
36. T. Ngandu, E. Von Strauss, and E.L. Helkala et al. Education and dementia: what lies behind the association? Neurology 69 14 2007 1442 1450 (Pubitemid 47511466)
37. C. Ferrari, B. Nacmias, and S. Bagnoli et al. Imaging and cognitive reserve studies predict dementia in presymptomatic Alzheimer's disease subjects Neurodegener Dis 2013
38. H.X. Wang, D.R. Gustafson, and M. Kivipelto et al. Education halves the risk of dementia due to apo lipoprotein epsilon4 allele: a collaborative study from the Swedish brain power initiative Neurobiol Aging 33 5 2012 1007.e1 1007.e7
39. M. Mortamais, F. Portet, and A.M. Brickman et al. Education modulates the impact of white matter lesions on the risk of mild cognitive impairment and dementia Am J Geriatr Psychiatry 2013
40. A. Soldan, C. Pettigrew, and S. Li et al. Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease Neurobiol Aging 2013
41. EClipSE Collaborative Members, Brayne C, Ince PG, et al. Education, the brain and dementia: Neuroprotection or compensation? Brain. 2010;133(Pt 8):2210-2216.
42. Y. Liu, V. Julkunen, and T. Paajanen et al. Education increases reserve against Alzheimer's disease - evidence from structural MRI analysis Neuroradiology 54 9 2012 929 938
43. M. Chang, P.V. Jonsson, J. Snaedal, S. Bjornsson, J.S. Saczynski, and T. Aspelund et al. The effect of midlife physical activity on cognitive function among older adults: AGES - reykjavik study J Gerontol A Biol Sci Med Sci 65 12 2010 1369 1374
44. F. Sofi, D. Valecchi, D. Bacci, R. Abbate, G.F. Gensini, and A. Casini et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies J Intern Med 269 1 2011 107 117
45. J.E. Ahlskog, Y.E. Geda, N.R. Graff-Radford, and R.C. Petersen Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging Mayo Clin Proc 86 9 2011 876 884
46. N. Scarmeas, J.A. Luchsinger, N. Schupf, A.M. Brickman, S. Cosentino, and M.X. Tang et al. Physical activity, diet, and risk of Alzheimer disease JAMA 302 6 2009 627 637
47. S. Rovio, I. Kareholt, E.L. Helkala, M. Viitanen, B. Winblad, and J. Tuomilehto et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease Lancet Neurol 4 11 2005 705 711 (Pubitemid 41457285)
48. S. Rovio, I. Kareholt, M. Viitanen, B. Winblad, J. Tuomilehto, and H. Soininen et al. Work-related physical activity and the risk of dementia and Alzheimer's disease Int J Geriatr Psychiatry 22 9 2007 874 882 (Pubitemid 47455270)
49. J. Verghese, W. Cuiling, M.J. Katz, A. Sanders, and R.B. Lipton Leisure activities and risk of vascular cognitive impairment in older adults J Geriatr Psychiatry Neurol 22 2 2009 110 118
50. S.L. Tyas, L.R. White, H. Petrovitch, G. Webster Ross, D.J. Foley, and H.K. Heimovitz et al. Mid-life smoking and late-life dementia: the Honolulu-Asia aging study Neurobiol Aging 24 4 2003 589 596 (Pubitemid 36513707)
51. M. Rusanen, M. Kivipelto, C.P. Quesenberry Jr., J. Zhou, and R.A. Whitmer Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia Arch Intern Med 171 4 2011 333 339
52. M. Rusanen, S. Rovio, T. Ngandu, A. Nissinen, J. Tuomilehto, and H. Soininen et al. Midlife smoking, Apo lipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study Dement Geriatr Cogn Disord 30 3 2010 277 284
53. T. Ngandu, E.L. Helkala, H. Soininen, B. Winblad, A. Nissinen, and J. Tuomilehto et al. Alcohol drinking and cognitive functions: findings from the cardiovascular risk factors aging and dementia (CAIDE) study Dement Geriatr Cogn Disord 23 3 2007 140 149 (Pubitemid 46333781)
54. A.K. Piazza-Gardner, T.J. Gaffud, and A.E. Barry The impact of alcohol on Alzheimer's disease: a systematic review Aging Ment Health 17 2 2013 133 146
55. F. Panza, V. Frisardi, D. Seripa, G. Logroscino, A. Santamato, and B.P. Imbimbo et al. Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry 27 12 2012 1218 1238
56. J.W. Kim, D.Y. Lee, B.C. Lee, M.H. Jung, H. Kim, and Y.S. Choi et al. Alcohol and cognition in the elderly: a review Psychiatry Investig 9 1 2012 8 16
57. E. Sinforiani, C. Zucchella, C. Pasotti, F. Casoni, P. Bini, and A. Costa The effects of alcohol on cognition in the elderly: from protection to neurodegeneration Funct Neurol 26 2 2011 103 106
58. P. Barberger-Gateau, C. Raffaitin, L. Letenneur, C. Berr, C. Tzourio, and J.F. Dartiques et al. Dietary patterns and risk of dementia: the three-city cohort study Neurology 69 20 2007 1921 1930 (Pubitemid 350100350)
59. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, and N. Aggarwal et al. Dietary fats and the risk of incident Alzheimer disease Arch Neurol 60 2 2003 194 200 (Pubitemid 36193962)
60. E.E. Devore, F. Grodstein, F.J. van Rooij, A. Hofman, M.J. Stampfer, and J.C. Witteman et al. Dietary antioxidants and long-term risk of dementia Arch Neurol 67 7 2010 819 825
61. N. Scarmeas, Y. Stern, M.X. Tang, R. Mayeux, and J.A. Luchsinger Mediterranean diet and risk for Alzheimer's disease Ann Neurol 59 6 2006 912 921 (Pubitemid 43830923)
62. D.A. Bennett, J.A. Schneider, Y. Tang, S.E. Arnold, and R.S. Wilson The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study Lancet Neurol 5 5 2006 406 412
63. P.A. Boyle, A.S. Buchman, R.S. Wilson, L. Yu, J.A. Schneider, and D.A. Bennett Effect of purpose in life on the relation between Alzheimer disease pathologic changes on cognitive function in advanced age Arch Gen Psychiatry 69 5 2012 499 505
64. R.S. Wilson, P.A. Scherr, J.A. Schneider, Y. Tang, and D.A. Bennett Relation of cognitive activity to risk of developing Alzheimer disease Neurology 69 20 2007 1911 1920 (Pubitemid 350100349)
65. K. Hakansson, S. Rovio, E.L. Helkala, A.R. Vilska, B. Winblad, and H. Soininen et al. Association between mid-life marital status and cognitive function in later life: population based cohort study BMJ 339 2009 b2462
66. C.C. Liu, T. Kanekiyo, H. Xu, and G. Bu Apo lipoprotein E and alzheimer disease: risk, mechanisms and therapy Nat Rev Neurol 9 2 2013 106 118
67. M. Kivipelto, S. Rovio, T. Ngandu, L. Kareholt, M. Eskelinen, and B. Winblad et al. Apo lipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study J Cell Mol Med 12 6B 2008 2762 2771
68. P. Hollingworth, D. Harold, R. Sims, A. Gerrish, J.C. Lambert, and M.M. Carrasquillo et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease Nat Genet 43 5 2011 429 435
69. J.C. Lambert, S. Heath, G. Even, D. Campion, K. Sleegers, and M. Hiltunen et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease Nat Genet 41 10 2009 1094 1099
70. J.C. Lambert, D. Zelenika, M. Hiltunen, V. Chouraki, O. Combarros, and M.J. Bullido et al. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations Neurobiol Aging 32 4 2011 756.e11 756.e15
71. J.C. Lambert, B. Grenier-Boley, D. Harold, D. Zelenika, V. Chouraki, and Y. Kamatani et al. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease Mol Psychiatry 18 4 2013 461 470
72. R.M. Conroy, K. Pyorala, and A.P. Fitzgerald et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 11 2003 987 1003 (Pubitemid 36712275)
73. J. Lindstrom, and J. Tuomilehto The diabetes risk score: a practical tool to predict type 2 diabetes risk Diabetes Care 26 3 2003 725 731 (Pubitemid 36929335)
74. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 18 1998 1837 1847 (Pubitemid 28213628)
75. M. Kivipelto, T. Ngandu, T. Laatikainen, B. Winblad, H. Soininen, and J. Tuomilehto Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study Lancet Neurol 5 9 2006 735 741 (Pubitemid 44205512)
76. Lieza G Exalto, Geert Jan Biessels, Andrew J Karter, Elbert S Huang, Wayne J Katon, Jerome R Minkoff, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: A cohort study. Advance online publication 20.08.2013.
77. L.G. Exalto, C.P. Quesenberry, D. Barnes, M. Kivipelto, G.J. Biessels, and R.A. Whitmer Midlife risk score for the prediction of dementia four decades later Alzheimers Dement 2013
78. D.E. Barnes, K.E. Covinsky, R.A. Whitmer, L.H. Kuller, O.L. Lopez, and K. Yaffe Predicting risk of dementia in older adults: the late-life dementia risk index Neurology 73 3 2009 173 179
79. C. Reitz, M.X. Tang, N. Schupf, J.J. Manly, R. Mayeux, and J.A. Luchsinger A summary risk score for the prediction of Alzheimer disease in elderly persons Arch Neurol 67 7 2010 835 841
80. F. Jessen, B. Wiese, H. Bickel, S. Eifflander-gorfer, A. Fuchs, and H. Kaduszkiewicz et al. Prediction of dementia in primary care patients PLoS One 6 2 2011 e16852
81. S. Kaffashian, A. Dugravot, A. Elbaz, M.J. Shipley, S. Sabia, and M. Kivimaki et al. Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores Neurology 80 14 2013 1300 1306
82. M. Van Oijen, F.J. De Jong, A. Hofman, P.J. Koudstaal, and M.M. Breteler Subjective memory complaints, education, and risk of Alzheimer's disease Alzheimers Dement 3 2 2007 92 97 (Pubitemid 46586160)
83. R.E. Amariglio, M.K. Townsend, F. Grodstein, R.A. Sperling, and D.M. Rentz Specific subjective memory complaints in older persons may indicate poor cognitive function J Am Geriatr Soc 59 9 2011 1612 1617
84. R.E. Amariglio, J.A. Becker, J. Carmasin, L.P. Wadsworth, N. Lorius, and C. Sullivan et al. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals Neuropsychologia 50 12 2012 2880 2886
85. D.G. Le Couteur, J. Doust, H. Creasey, and C. Brayne Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis BMJ 347 2013 f5125
86. Bethesda M. National institutes of health. Consensus development conference statement on preventing Alzheimer's disease and cognitive Decline2010.;2010(10/7/2013).
87. F. Mangialasche, M. Kivipelto, A. Solomon, and L. Fratiglioni Dementia prevention: current epidemiological evidence and future perspective Alzheimers Res Ther 4 1 2012 6
88. Z.S. Khachaturian, R.C. Petersen, S. Gauthier, N. Buckholtz, J.P. Corey-bloom, and B. Evans et al. A roadmap for the prevention of dementia: the inaugural Leon Thal symposium Alzheimers Dement 4 3 2008 156 163 (Pubitemid 351682266)
89. E. Richard, S. Andrieu, A. Solomon, F. Mangialasche, S. Ahtiluoto, and E.P. Moll van Charante et al. Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI) J Neurol Sci 322 1-2 2012 64 70
90. Prevent Alzheimer's disease 2020, inc. - about. http://www.pad2020.org. Accessed 10/7/2013, 2013.
91. M. Kivipelto, A. Solomon, S. Ahtiluoto, T. Ngandu, J. Lehtisalo, and R. Antikainen et al. The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER): study design and progress Alzheimers Dement 2013
92. I. Carrie, G.A. Van Kan, S. Gillette-Guyonnet, S. Andrieu, J.F. Dartiques, and J. Touchon et al. Recruitment strategies for preventive trials. the MAPT study (Multidomain alzheimer preventive trial) J Nutr Health Aging 16 4 2012 355-r 359
93. E. Richard, E. Van den Heuvel, E.P. Moll van Charante, L. Achthoven, M. Vermeulen, and P.J. Bindels Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress Alzheimer Dis Assoc Disord 23 3 2009 198 204
94. J. Tuomilehto, J. Lindstrom, J.G. Eriksson, T.T. Valle, H. Hamalainen, and P. Ilanne-Parikka et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 18 2001 1343 1350 (Pubitemid 32378388)
95. C. Qiu, E. Von Strauss, L. Backman, B. Winblad, and L. Fratiglioni Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden Neurology 80 20 2013 1888 1894
96. A. Ruitenberg, S. Kalmijn, M.A. De Ridder, W.K. Redekop, F. Van Harskamp, and A. Hofman et al. Prognosis of Alzheimer's disease: the Rotterdam study Neuroepidemiology 20 3 2001 188 195 (Pubitemid 32718876)
97. F.E. Matthews, A. Arthur, L.E. Barnes, J. Bond, C. Jagger, and L. Robinson et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the cognitive function and ageing study I and II Lancet 2013
98. S. Gillette-Guyonnet, S. Andrieu, T. Dantoine, J.F. Dartiques, J. Touchon, and B. Vellas et al. Commentary on A roadmap for the prevention of dementia II Leon Thal Symposium 2008. The Multidomain Alzheimer Preventive trial (MAPT): a new approach to the prevention of Alzheimer's disease Alzheimers Dement 5 2 2009 114 121